DURECT Corporation (DRRX)
NASDAQ$0.86
Market Cap
$26.7M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
560 of 924
Rank in Industry
31 of 56
Insider Buys Sum
Cluster
Trading
Trading
Insider Buys
Quantity
Quantity
Historical
Profitability
Profitability
Investor
Ownership
Ownership
Largest Insider Buys in Sector
DRRX Insider Trading Activity
DRRX Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Related Transactions
No records found
About DURECT Corporation
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat …
Insider Activity of DURECT Corporation
Over the last 12 months, insiders at DURECT Corporation have bought $0 and sold $0 worth of DURECT Corporation stock.
On average, over the past 5 years, insiders at DURECT Corporation have bought $136,377 and sold $343,993 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 9,412 shares for transaction amount of $8,000 was made by Robertson Judith J. () on 2022‑08‑18.
List of Insider Buy and Sell Transactions, DURECT Corporation
| 2022-08-18 | Robertson Judith J. | 9,411.76 0.0041% | $0.85 | $8,000 | -41.06% | |||
| 2022-08-17 | Robertson Judith J. | 8,130 0.0035% | $0.85 | $6,906 | -42.30% | |||
| 2022-08-12 | Maderis Gail J | 25,204 0.0101% | $0.71 | $17,993 | -35.26% | |||
| 2022-08-09 | Maderis Gail J | 79,693 0.037% | $0.69 | $54,661 | -22.00% | |||
| 2022-05-26 | Robertson Judith J. | 65,000 0.0285% | $0.39 | $25,597 | +30.77% | |||
| 2022-05-24 | AZAB MOHAMMAD | 5,000 0.0021% | $0.39 | $1,950 | +26.50% | |||
| 2022-05-16 | Farfel Gail M | 29,911 0.0142% | $0.41 | $12,201 | +31.58% | |||
| 2022-05-16 | AZAB MOHAMMAD | 1,800 0.0009% | $0.42 | $758 | +31.58% | |||
| 2022-05-11 | Farfel Gail M | 9,250 0.0041% | $0.40 | $3,700 | +25.00% | |||
| 2022-05-10 | Farfel Gail M | 2,339 0.001% | $0.41 | $950 | +19.05% | |||
| 2022-05-09 | Farfel Gail M | 4,250 0.0019% | $0.40 | $1,679 | +28.21% | |||
| 2022-03-14 | Robertson Judith J. | 200,000 0.0937% | $0.59 | $118,000 | -6.36% | |||
| 2021-12-10 | Sale | Sussman Norman | Chief Medical Officer | 9,000 0.0041% | $1.05 | $9,495 | -45.10% | |
| 2021-12-07 | BENITO SIMON X | director | 20,000 0.009% | $1.02 | $20,360 | -43.00% | ||
| 2021-05-14 | Sale | Joice Judy R | Sr. VP Operations & Corp QA | 60,137 0.0003% | $1.72 | $103,682 | -34.01% | |
| 2020-09-01 | Sale | Bleichroeder LP | 10 percent owner | 250,000 0.0012% | $1.68 | $420,000 | +6.89% | |
| 2020-06-03 | Sale | Joice Judy R | Sr. VP Operations & Corp QA | 22,956 0.0001% | $2.45 | $56,284 | -18.16% | |
| 2020-05-26 | Sale | Bleichroeder LP | 10 percent owner | 39,388 0.0002% | $2.50 | $98,525 | -24.06% | |
| 2020-02-06 | Bleichroeder LP | 10 percent owner | 75,000 0.0004% | $1.65 | $123,623 | +23.31% | ||
| 2020-02-05 | Bleichroeder LP | 10 percent owner | 74,998 0.0004% | $1.69 | $126,777 | +18.24% |
Total: 92
Insider Historical Profitability
34.9%
| First Eagle Investment Management, LLC | 10 percent owner | 26476546 85.2927% | $22.77M | 2 | 0 | +227.59% |
| Bleichroeder LP | 10 percent owner | 26414656 85.0933% | $22.72M | 3 | 2 | +19.47% |
| 21 APRIL FUND, LTD. | 10 percent owner | 22381546 72.1009% | $19.25M | 11 | 0 | +15.15% |
| THEEUWES FELIX | Chairman and CSO | 3396314 10.941% | $2.92M | 20 | 0 | +41.12% |
| SCHRECK THOMAS A | Chief Financial Officer | 1865000 6.008% | $1.6M | 2 | 0 | +101.37% |
Historical Insider Profitability vs. Competitors
$2,051,022 | 1591 | -12.84% | $76.27M | |
DURECT Corporation (DRRX) | $22,899,264 | 81 | 34.90% | $26.7M |
$125,860,243 | 57 | -4.48% | $54.94M | |
$2,740,482 | 50 | 9.37% | $36.33M | |
$30,209,812 | 45 | -1.91% | $8.36M |
DRRX Institutional Investors: Active Positions
| Increased Positions | 19 | +40.43% | 318,337 | +4.47% |
| Decreased Positions | 16 | -34.04% | 585,526 | -8.21% |
| New Positions | 5 | New | 46,959 | New |
| Sold Out Positions | 5 | Sold Out | 61,754 | Sold Out |
| Total Postitions | 50 | +6.38% | 7M | -3.75% |
DRRX Ownership Change vs Market
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
| Ingalls & Snyder Llc | $1,270.00 | 5.13% | 1.59M | -393,767 | -19.84% | 2024-12-31 |
| Richmond Brothers, Inc. | $1,022.00 | 4.13% | 1.28M | +138,920 | +12.16% | 2024-12-31 |
| Vanguard Group Inc | $909.00 | 3.67% | 1.14M | 0 | 0% | 2024-12-31 |
| Gagnon Securities Llc | $321.00 | 1.3% | 402,013 | +8,151 | +2.07% | 2024-12-31 |
| Geode Capital Management, Llc | $263.00 | 1.06% | 328,991 | +9,086 | +2.84% | 2024-12-31 |
| Beirne Wealth Consulting Services, Llc | $260.00 | 1.05% | 325,875 | -50,501 | -13.42% | 2024-12-31 |
| Montchanin Asset Management, Llc | $247.00 | 1% | 310,118 | +6,086 | +2% | 2024-12-31 |
| Blackrock, Inc. | $224.00 | 0.91% | 280,818 | 0 | 0% | 2024-12-31 |
| Dalton Investments, Inc. | $196.00 | 0.79% | 245,000 | +20,000 | +8.89% | 2024-12-31 |
| Ironwood Investment Management Llc | $137.00 | 0.55% | 171,832 | -405 | -0.23% | 2024-12-31 |
Financial Ratios
Summary
Comparison with Competitors
Analyst Recommendations
Analyst Price Targets
No data is available at this moment.
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.